Literature DB >> 23706874

The incidence and risk factors for blood transfusion in revision shoulder arthroplasty: our institution's experience and review of the literature.

Shahryar Ahmadi1, Thomas M Lawrence1, Shawn Sahota1, Cathy D Schleck1, William S Harmsen1, Robert H Cofield1, John W Sperling2.   

Abstract

HYPOTHESIS: The purposes of this study were to determine the incidence of blood transfusion after revision shoulder arthroplasty and to assess risk factors associated with an increased risk of transfusion.
MATERIALS AND METHODS: Between 1994 and 2008, 566 consecutive revision shoulder procedures were performed at our institution, which formed the basis of this study. The patient's age, sex, body mass index, comorbidities, preoperative and postoperative hemoglobin level, details of the surgery, operative time, and transfusion details were documented retrospectively from medical records.
RESULTS: Overall, 11.3% of patients (64 of 566) required a transfusion. An increased transfusion rate was associated with age (odds ratio [OR] per 10 years, 1.5 [95% confidence interval (CI), 1.2 to 2.0]; P = .002), operative time (≤ 5 hours vs >5 hours) (OR, 3.3 [95% CI, 1.9 to 5.8]; P < .001), diabetes (OR, 2.3 [95% CI, 1.2 to 4.4]; P = .01), and cardiac disease (OR, 2.7 [95% CI, 1.5 to 5.0]; P < .001). There were significant associations between preoperative hemoglobin level (OR, 0.4 per 1 point [95% CI, 0.3 to 0.5]; P < .001) and a decreased odds of transfusion. The type of surgery (surgery on humeral component) also had an impact on the need for transfusion (P < .001).
CONCLUSIONS: Older age, low preoperative hemoglobin level, increased operative time, diabetes, presence of cardiac disease, and type of revision surgery are associated with higher postoperative transfusion rates. These factors should be taken into consideration to more accurately predict the need for transfusion and modify preoperative blood-ordering protocols.
Copyright © 2014 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Blood transfusion; Case Series; Level IV; Treatment Study; incidence and risk factors; revision shoulder arthroplasty

Mesh:

Year:  2013        PMID: 23706874     DOI: 10.1016/j.jse.2013.03.010

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  12 in total

1.  Management of complications after revision shoulder arthroplasty.

Authors:  Hithem Rahmi; Andrew Jawa
Journal:  Curr Rev Musculoskelet Med       Date:  2015-03

2.  Onsets of complications and revisions are not increased after simultaneous bilateral unicompartmental knee arthroplasty in comparison with unilateral procedures.

Authors:  Sergio Romagnoli; Sara Zacchetti; Paolo Perazzo; Francesco Verde; Giuseppe Banfi; Marco Viganò
Journal:  Int Orthop       Date:  2014-10-14       Impact factor: 3.075

3.  Drain Use is Associated with Increased Odds of Blood Transfusion in Total Shoulder Arthroplasty: A Population-Based Study.

Authors:  Jimmy J Chan; Carl M Cirino; Hsin-Hui Huang; Jashvant Poeran; Madhu Mazumdar; Bradford O Parsons; Shawn G Anthony; Leesa M Galatz; Paul J Cagle
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

4.  Topical and Intravenous Tranexamic Acid Are Equivalent in Decreasing Blood Loss in Total Shoulder Arthroplasty.

Authors:  Matthew Budge
Journal:  J Shoulder Elb Arthroplast       Date:  2019-05-30

5.  Impact of tranexamic acid on clinical and hematologic outcomes following total shoulder arthroplasty.

Authors:  McKayla Kelly; Justin Turcotte; M Brook Fowler; Michaline West; Cyrus Lashgari; Jeffrey Gelfand
Journal:  Shoulder Elbow       Date:  2021-07-26

6.  Blood transfusion rates following shoulder arthroplasty in a high volume UK centre and analysis of risk factors associated with transfusion.

Authors:  P J Dacombe; J V Kendall; Pas McCann; I N Packham; P P Sarangi; M R Whitehouse; M A Crowther
Journal:  Shoulder Elbow       Date:  2018-05-14

7.  Risk factors for and timing of adverse events after revision total shoulder arthroplasty.

Authors:  Aakash Keswani; Debbie Chi; Andrew J Lovy; Daniel A London; Paul J Cagle; Bradford O Parsons; Joseph A Bosco
Journal:  Shoulder Elbow       Date:  2018-06-12

Review 8.  Inconclusive evidence for the efficacy of tranexamic acid in reducing transfusions, postoperative infection or hematoma formation after primary shoulder arthroplasty: A meta-analysis with trial sequential analysis.

Authors:  Jorge Rojas; Uma Srikumaran; Edward G McFarland
Journal:  Shoulder Elbow       Date:  2020-01-13

9.  Tranexamic acid use is associated with lower transfusion rates in shoulder arthroplasty patients with preoperative anaemia.

Authors:  T Bradly Clay; A Sayo Lawal; Thomas W Wright; Matthew Patrick; Aimee M Struk; Kevin W Farmer; Joseph J King
Journal:  Shoulder Elbow       Date:  2019-04-10

10.  Tranexamic acid decreases blood loss in shoulder arthroplasty: A meta-analysis.

Authors:  Bin-Feng Yu; Guo-Jing Yang; Qi Li; Liang-le Liu
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.